Pathogenic TNNT1 variants are associated with aberrant thin filament compliance and myofibre hyper‐contractility

Figures

• 

  Figure 1. Histological abnormalities A, representative muscle cross‐sections from one control and two patients. These patients classified as mild or severe (Table 1) have varying expressions of ssTnT and fsTnT in slow twitch (MyhI) and fast twitch (MyHIIA) muscle fibres. Magnification, 10×; scale bar = 100 µm. B and C, fibre type proportions are displayed for controls and for all pooled patients (B) or for patients separated according to their phenotypes: mild or severe (C). D and E, similarly, cross‐sectional areas (CSAs) for both slow and fast twitch fibres are presented for controls and pooled patients (D) or mild/severe cases (E). Mean, standard deviations and/or individual data points (circles) are shown. Two‐way ANOVAs with Tukey's post hoc test were applied to compare groups (level of significance P < 0.05). [Colour figure can be viewed at wileyonlinelibrary.com]

• 

  Figure 2. TnT post‐translational modifications A–D, the Z‐score for two specific post‐translational modifications, Lys58‐Ac and Ser148‐P. Mean, standard deviations and/or individual data points (circles) are presented. Unpaired t tests with Welch correction (A and B) or one‐way ANOVAs with Tukey's post hoc test (C and D) were used to compare groups (level of significance P < 0.05). E, an overview of the mutations (in green) and post‐translational modifications (in red) along the sequence/exons of TnT. Regions where tropomyosin as well as troponin I and C bind are also shown. [Colour figure can be viewed at wileyonlinelibrary.com]

• 

  Figure 3. Model of fsTnT in the thin filament junction A, cartoon representation of the human skeletal thin filament junction after energy minimization, showing fsTnT (orange), tropomyosin (blue) and actin (white, with the subunits interacting with fsTnT coloured in grey). The region with altered interaction patterns in WT and Lys58Gln MD trajectories is highlighted in magenta. B and C, close‐up view of the fsTnT (orange liquorice) and actin (grey) residues involved in altered HB interactions (B) and inter‐residue contacts (C). [Colour figure can be viewed at wileyonlinelibrary.com]

• 

  Figure 4. Rewiring of the HB network illustrated with WT structures A, occupancy of HB interactions (calculated as the percentage of frames where a given HB interaction is observed) for selected residue pairs from fsTnT and actin. Average values calculated over five replicas are shown for Lys58Gln (orange) and WT (dark orange) MD simulations, with the standard deviation of the mean shown as a bar. Values calculated for both sets of chains (fsTnT chains K and P, and actin chains C and D) are shown for each interaction. B and C, representative structures extracted through a cluster analysis of WT trajectories to illustrate the HB interactions 1–4, which are on average stronger in WT than Lys58Gln simulations. A close‐up view of residues from the P (fsTnT) and D (actin) chains is shown. [Colour figure can be viewed at wileyonlinelibrary.com]

• 

  Figure 5. Rewiring of the HB network illustrated with Lys58Gln structures A, occupancy of HB interactions (calculated as the percentage of frames where a given HB interaction is observed) for selected residue pairs from fsTnT and actin. Average values calculated over five replicas are shown for Lys58Gln (orange) and WT (dark orange) MD simulations, with the standard deviation of the mean shown as a bar. Values calculated for both sets of chains (fsTnT chains K and P, and actin chains C and D) are shown for each interaction. B and C, representative structures extracted through a cluster analysis of Lys58Gln trajectories to illustrate the HB interactions 5–7, which are on average stronger in Lys58Gln than WT simulations. A close‐up view of residues from the K (fsTnT) and C (actin) chains is shown. [Colour figure can be viewed at wileyonlinelibrary.com]

• 

  Figure 6. Contact analysis A and B, occupancy of contacts (calculated as the fraction of frames where a given contact is observed) for selected residue pairs from fsTnT and actin. Average values calculated over five replicas are shown for Lys58Gln (orange) and WT (dark orange) MD simulations, with the standard deviation of the mean shown as a bar. Values calculated for fsTnT (chain K) – actin (chain C) and fsTnT (chain P) – actin (chain D) pairs are shown in A and B, respectively. [Colour figure can be viewed at wileyonlinelibrary.com]

• 

  Figure 7. Thin filament compliance A, typical X‐ray diffraction patterns obtained from one control and one mild patient. B, the meaning of the two main reflections studied here, i.e. the 6th actin layer line, ALL6, and 3rd troponin reflection, TN3. C, D and E, mean and standard deviations. Unpaired t‐tests with Welch correction were used to compare groups (level of significance P < 0.05). [Colour figure can be viewed at wileyonlinelibrary.com]

• 

  Figure 8. Myofibre Ca2+ sensitivity A, representative force–pCa curves from one control and one mild patient. B and C, Ca2+ sensitivity is displayed for controls and for all pooled patients (B) or for patients separated according to their phenotypes: mild or severe (C). D and E, correlations between Ca2+ sensitivity and Lys58‐Ac Z‐score (D) or Ser148‐P Z‐score (E). F and G, specific force is shown for controls and for all patients (F) or for mild vs. severe patients (G). Mean, standard deviations and/or individual data points (circles) are shown. A mixed effects models were used to analyse the data as previously published (Krivickas et al., 2011) (level of significance P < 0.05). * P < 0.05. Otherwise, for D and E, regression analyses were performed and the R 2 is presented for the only significant correlation. [Colour figure can be viewed at wileyonlinelibrary.com]

• 

  Figure 9. Muscle fibre response to a contractile inhibitor A–D, Ca2+ sensitivity in both slow twitch and fast twitch muscle fibres with varying concentrations of mavacamten (0, 1, 5 and 10 µM). Individual data points (circles) are shown for pooled patients or patients divided according to their phenotypes: mild or severe. Two‐way ANOVAs with repeated measures and post hoc analyses were performed with P < 0.05 as level of significance (Factor 1: group of individuals – Factor 2: mavacamten concentration). *Differences when compared with 0 µM mavacamten, irrespective of the group. [Colour figure can be viewed at wileyonlinelibrary.com]